CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

NGL FINE-CHEM LTD.

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE2151.95-187.9 (-8.03 %)
PREV CLOSE () 2339.85
OPEN PRICE () 2329.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2765
TODAY'S LOW / HIGH ()2098.55 2329.00
52 WK LOW / HIGH ()985.05 2596
NSE2150.20-183.4 (-7.86 %)
PREV CLOSE() 2333.60
OPEN PRICE () 2345.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13325
TODAY'S LOW / HIGH() 2115.40 2345.30
52 WK LOW / HIGH ()980 2575
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1981

Management Info :

Dhananjay Mungale - Chairman Rahul Nachane - Managing Director

Registered Office :

Address : 301 E Square,Subhash Road,Vile Parle (East),
Mumbai,
Maharashtra-400057

Phone : 022 26636450

Registrar's Details : Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE, NSE
NEWS
13Mar NGL Fine-Chem informs about credit rat
Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Obl..
03Jan NGL Fine-Chem informs about certifica
Based on the confirmation received from Purva Sharegistry (I), Registrar..
25Jul NGL Fine-Chem submits BRSR
Pursuant to Regulation 34(2)(f) of the Securities and Exchange Board of..
10Jul NGL Fine Chem informs about compliance
NGL Fine Chem has informed that it enclosed compliance certificate under..
27Jun NGL Fine-Chem informs about credit rat
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit147.36181.32
Gross Profit 193.74 238.82
Operating Profit 247.8354.59
Net Sales 1263.313592.94
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26916.10 (0.83%)
M.Cap ( in Cr)
57194.83
BDH Inds (BSE)
 402.35 (9.92%)
M.Cap ( in Cr)
231.64
Onesource Specialty (BSE)
 1488.70 (1.43%)
M.Cap ( in Cr)
17063.66
Mercury Laboratories (BSE)
 800.00 (2.56%)
M.Cap ( in Cr)
96.00
Strides Pharma Scien (BSE)
 922.25 (1.19%)
M.Cap ( in Cr)
8500.63
Shareholding Pattern
PROMOTERS 72.74%
NON-INSTITUTION 27.26%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX74563.92-1470.50 (-1.93%)
NIFTY23151.10-488.05 (-2.06%)
Dow Jones 46558.47-119.38 (-0.26%)
Nasdaq 22105.36-206.62 (-0.93%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI